MedPage Today: The cumulative malaria incidence was significantly lower over 18 weeks in the intervention group who received the drug than among controls (estimated mean 2.00 episodes/child vs estimated mean 2.49 episodes/child, respectively; risk difference -0.49, 95% CI -0.79 to -0.21, P=0.0009), reported Brian D. Foy, PhD, of Colorado State University in Fort Collins, and colleagues, writing in The Lancet.

link